The exclusive agreement follows an extensive product evaluation assessment with the goal of introducing ActiGraft to hospitals and wound care centers on the path towards commercial scale
RedDress, developers of the ActiGraft system, a personalized and autologous wound care solution created from patients own whole blood, today announced that it has established a strategic partnership with OneMed, part of the Asker Healthcare Group, to commercialize and distribute the ActiGraft system throughout Finland and Sweden. The multinational agreement is exclusive and follows an extensive product evaluation assessment.
The wound care market in the Nordics is growing due to an aging population and the increased prevalence of chronic diseases. At the same time, Nordic countries are facing a severe lack of healthcare personnel, especially among nurses and wound care specialists. In order to help healthcare providers, innovative wound care solutions are required so patients are able to obtain the most adequate care.
The ActiGraft wound care system is an autologous, point-of-care wound management solution created from the patient’s whole blood. Once applied, the blood clot serves as a protective covering and optimizes the body’s own healing potential. Applied directly to the wound surface, the ActiGraft blood clot is created at the patient’s bedside in eight minutes by mixing fresh whole blood with our proprietary coagulation powder. ActiGraft contains whole blood cells including white cells, red cells, plasma, platelets, and fibrin, in the optimal concentration required in the wound healing process. Once applied, ActiGraft reignites the healing cascade, serving as a protective covering that supports wound healing processes which occur naturally in the body.
“We are very excited to announce this strategic partnership with OneMed to bring our leading chronic wound care solution to the Nordics”, said Alon Kushnir, CEO and Co-Founder at RedDress. “This is a very important European market and we are confident that together with OneMed, we will impact the treatment of chronic wounds for patients and care providers through faster healing and lower costs.”
“We are thrilled to be partnering with RedDress to bring their advanced wound care solution to market in the Nordics,” said Hanna Merikanto, Business Unit Director of OneMed. “This is a totally new and simple way of treating chronic wounds, and pilot studies underway in Finland have already shown healing results that are remarkable. We strongly believe that the ActiGraft wound care system will bring immense benefits for patients suffering from non-healing wounds, and an ease of treatment for care providers.”
Source: Company Press Release